![]() |
|
#1
|
|||
|
|||
|
(Reuters) - U.S. biotech**logy company Celgene Corp reported a better-than-expected quarterly profit and raised its adjusted earnings forecast for 2016 due to higher demand for its key multiple myeloma drug, Revlimid. ??????? ??????: U.S. biotech Celgene raises forecast as profit beats Street || ??????: ahlam1399 || ??????: اسم منتداك
|
![]() |
|
|